首页 / 资料库 / 文献详情

[Pathomechanisms of pericyte-myofibroblast transition in kidney and interventional effects of Chinese herbal medicine].

Yinglu LiuGe ShiDongwei CaoYi‐Gang WanWei WuYue TuBu-Hui LiuWen-Bei Han

2018PubMedMedicine被引 2

出版方页面 →

摘要

In the kidney, pericyte is the major source of myofibroblast (MyoF) in renal interstitium. It is reported that pericyte-myofibroblast transition(PMT)is one of the important pathomechanisms of renal interstitial fibrosis(RIF). Among them, the main reasons for promoting RIF formation include pericyte recruitment, activation and isolation, as well as the lack of pericyte-derived erythropoietin. During the PMT startup process, pericyte activation and its separation from microvessels are controlled by multiple signal transduction pathways, such as transforming growth factor-β(TGF-β)pathway, vascular endothelial growth factor receptor (VEGFR) pathway and platelet derived growth factor receptor (PDGFR) pathway;Blocking of these signaling pathways can not only inhibit PMT, but also suppress renal capillaries reduction and further alleviate RIF. In clinic, many traditional Chinese medicine compound prescriptions, single traditional Chinese herbal medicine (CHM) and their extracts have the clear effects in alleviating RIF, and some of their intervention actions may be related to pericyte and its PMT. Therefore, the studies on PMT and its drug intervention will become the main development direction in the research field of anti-organ fibrosis by CHM.

引用本文(GB/T 7714)

Yinglu Liu, Ge Shi, Dongwei Cao, 等. [Pathomechanisms of pericyte-myofibroblast transition in kidney and interventional effects of Chinese herbal medicine].[J]. PubMed, 2018.

引文网络

参考文献与被引分析加载中…

DOI:https://doi.org/10.19540/j.cnki.cjcmm.20180531.002

本站仅收录题录与摘要供学习参考,全文版权归属出版方;如有侵权请联系我们删除。